Primary Menu
        * Portfolio
        * Team
        * Contact
        * Investor Login

          Investing in Breakthroughs

            Who We Are

            +ND Capital (f.k.a. NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences. Our core belief is that scientific disciplines will continue to converge, and that some of the biggest breakthroughs will be based on this convergence. We invest across the United States and Europe, and through our teams in Silicon Valley, Switzerland and the Cayman Islands, we can help our portfolio companies bridge the Atlantic to attract capital, talent, and business partners.

            Assets Under Management (AUM)~$820M
            Our third fund with $335M AUM is fully invested and we have begun investing in our fourth fund with a target size of $350M.

            We invest across sectors, stages and technologies. We operate as one team, working together to identify and evaluate investment opportunities and to help our portfolio companies succeed. We think like company owners and help build world-class, impactful, lasting companies. We value creativity, intellect, passion and believe in respect and perseverance.

          Portfolio

              All Physical Science Life Science

                    Alumni

                    Alumni

                    Alumni

                    Alumni

                    Alumni

                    Alumni

                Alumni

                Alumni

                Alumni

                Alumni

                Alumni

                Alumni

          Meet The Team

                  Aymeric Sallin

                  Founder & Chief Executive Officer

                    ×

                      Aymeric Sallin

                      Founder & Chief Executive Officer

                      as@nd.capital

                      Aymeric founded +ND Capital in 2002. He discovered the nanotechnology world while conducting research between the Physics and Chemistry departments of EPFL in the 90’s. He was convinced that significant breakthroughs would arise at the nanoscale and extensive expertise would be required to differentiate science from science fiction. This was the foundation of +ND Capital. Following the raise of the first ND partnership, Aymeric realized that despite great science in Europe, the US was offering better investment opportunities. As a consequence, he has been commuting between Switzerland and Boston/ Silicon Valley since 2007. Prior to this, Aymeric was a strategy consultant with Bain & Company.

                      He is currently a board member of Crocus Technology, H55, Natron Energy, Tarveda Therapeutics, and Selecta Biosciences.

                      Aymeric is an elected member of the World Economic Forum’s “Young Global Leaders” Class of 2013 and the Swiss Academy of Engineering Sciences (2016). He received the “2007 NSTI Fellow Award” and “2012 EPFL Alumni” award.

                      Aymeric holds a Masters in Physical Engineering from EPFL where he is still an active member of the SAB and Chairman of the alumni association.

                  Eric Moessinger

                  Partner

                    ×

                      Eric Moessinger

                      Partner

                      em@nd.capital

                      Eric joined +ND Capital in 2008 and was the first employee of our Silicon Valley office. He is focused on life sciences investments. Eric is currently a board member of Emulate, Visby Medical, AIRNA, Partillion, Osasuna and a board observer of Lightcast, IonPath and Inscripta. He was previously a board member of Icosavax (Acquired by AZ), Serotiny (Acquired by J&J), SQZ Biotech (NYSE: SQZ), and observed on the boards of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Eric also helped lead +ND Capital’s investments in Orca, Octant and Nutcracker.

                      Before joining +ND Capital, Eric was a consultant at Bain & Company in Zurich and San Francisco. While at Bain, Eric worked on strategy cases in healthcare, industrial goods and telecommunications and on the turn-around of an electrical component manufacturer. In addition, Eric spent eight months in Bain’s Private Equity Group.

                      Eric has an MSc from the London School of Economics and a BS/BA from the University of Florida.

                  Kirill Kuzmichev

                  Principal

                    ×

                      Kirill Kuzmichev

                      Principal

                      kk@nd.capital

                      Kirill joined +ND Capital in our Silicon Valley office in 2013. He is focused on physical science investments and is currently a board observer of SiMa.ai and Spark Microsystems.

                      Prior to this, he worked with Rusnano, a Russian nanotechnology initiative, where he sourced, structured, and managed nanotech-related deals starting in 2009. Before Rusnano, Kirill worked for four years at a Russian private equity fund and was in charge of several investments in logistics, pharmaceuticals, and technology. Kirill also worked in various positions as an engineer, consultant (Boston Consulting Group), and operational manager in Korea, U.S., U.K., and Russia.

                      Kirill holds a Masters in Computer Science from the Electrotechnical University of St. Petersburg as well as an MBA from INSEAD, France.

                  Peter Liddiard

                  Chief Operating Officer & Chief Financial Officer

                    ×

                      Peter Liddiard

                      Chief Operating Officer & Chief Financial Officer

                      pl@nd.capital

                      Peter joined +ND Capital in our Silicon Valley office in 2019. He has 25 years of experience as an investment executive including listed equities, private equity, and venture capital in the USA, UK, Europe, Asia, and South Africa. His sector experience includes Technology, Life Sciences, Physical Sciences, Consumer, Property, and Infrastructure. He has been on the board and sub-committees of 15 companies ranging from early-stage to a FTSE 100 company. He is currently a board observer of Natron Energy.

                      Peter’s original work experience was in South Africa where he qualified as a Chartered Accountant in 1994 and is a member of the South African Institute of Chartered Accountants. He completed an Advanced Management Program at Harvard Business School in 2013.

                  Jonathan Nicholson

                  Executive Director of the General Partner

                    ×

                      Jonathan Nicholson

                      Executive Director of the General Partner

                      jn@nd.capital

                      Jonathan joined +ND Capital in 2005 and is based in our Grand Cayman office. He is the former Managing Director of Merrill Lynch Bank & Trust Company and Head of Corporate Management at KPMG in the Cayman Islands. He has an extensive background as a director of several important and sizeable investment entities.

                      Jonathan is a Fellow of the Institute of Chartered Accountants in England and Wales.

                  Richard Coles

                  Director of the General Partner

                    ×

                      Richard Coles

                      Director of the General Partner

                      rc@nd.capital

                      Richard joined + ND Capital in 2006 and is based in our Grand Cayman office. He is an experienced lawyer both in England and in the Cayman Islands, being a Solicitor admitted in England, a Cayman Islands Attorney-at-law and Notary Public. He was for 6 years the Attorney General for the Cayman Islands, a Member of the Cabinet and Legislative Assembly, and a Government Minister having been appointed to that position on the recommendation of the British Government. He was also acting Governor of the Cayman Islands. Prior to that appointment, he was the founding partner of a substantial firm of solicitors with offices in England.

                      Richard is now a non-executive director of a number of hedge funds and investment companies. Former chairman Cayman Finance; Human Rights Commission; Anti-Corruption Commission.

                      Richard studied at the College of Law in London and is a Fellow of the Caribbean Law Institute. He is a member of the Law Society of England, the Commonwealth Lawyers Association, the Commonwealth Parliamentary Association, and the Institute of Advanced Legal Studies in London. He also has the distinction of being a Freeman of the City of London.

                  Alison Palmer

                  Vice President of the General Partner

                    ×

                      Alison Palmer

                      Vice President of the General Partner

                      ap@nd.capital

                      Alison joined +ND Capital in 2021 and is based in our Grand Cayman office.

                      Alison has extensive experience in the financial services industry, with a focus on private equity and hedge funds. She spent 8 years working in fund administration and 5 years in audit working for PricewaterhouseCoopers in Grand Cayman and for KPMG in Cape Town.

                      Alison qualified as a chartered accountant in South Africa and is a member of the South African Institute of Chartered Accountants and the Cayman Islands Institute of Professional Accountants. She holds a Bachelor of Business Science (Finance Honours) and Postgraduate Diploma in Accounting, both obtained from the University of Cape Town.

                  Gabriela Ecco

                  Principal

                    ×

                      Gabriela Ecco

                      Principal

                      ge@nd.capital

                      Gabriela joined +ND Capital in our Lausanne office in 2021 and is currently a board observer of EVIR Therapeutics, Vandria and Osasuna Therapeutics. She is also a board observer of AIRNA and a former board observer of Cellpoint (sold to Galapagos).

                      Prior to this, Gabriela has accumulated 15 years of experience in R&D in academia and industry. She has contributed to different areas of life sciences, including molecular and structural biology, infectious diseases, embryonic stem cells biology, tissue engineering, epigenetics, bioinformatics, and cancer molecular diagnostics. During her career, Gabriela has authored several high-impact peer-reviewed scientific publications and has led the development of different products for molecular diagnostics in oncology. Gabriela is passionate about science and innovation and her motivation is to help bring to the market new technologies that can change people’s lives.

                      Gabriela holds a PhD in Biotechnology and Bioengineering from EPFL and a Certificate of Advanced Studies (CAS) in Management of Biotech, Medtech and Pharma Ventures from EPFL.

            MEET COMPLETE TEAM
                USA +

                  2983 Woodside Road
                  Woodside, CA 94062

                  tel: +1 650 241 1155
                  email: info@nd.capital

                Switzerland +
                    * Millennium Building
                      Chemin de Mongevon 25
                      1023 Crissier
                      Switzerland
                    * Sihlamtsstrasse 5
                      CH-8001 Zürich
                      Switzerland

                  tel: +41 21 561 33 00
                  email: info@nd.capital

                Cayman Island +

                  Governor’s Square, Unit 3-113B
                  P.O. Box 526 WB
                  23, Lime Tree Bay Ave
                  Grand Cayman, KY1-1302
                  Cayman Islands

                  tel: +1 345 516 0210
                  email: info@nd.capital

        © Copyright 2025 ND Capital. All Rights Reserved.

        Web Development San Francisco by Thomas Digital

  * Portfolio
  * Team
  * Contact
  * Investor Login